Endoscopic Center, XingTai People's Hospital, Xingtai 054001, China.
Department of Pathology, XingTai People's Hospital, Xingtai 054001, China.
Contrast Media Mol Imaging. 2022 Jul 8;2022:5248256. doi: 10.1155/2022/5248256. eCollection 2022.
To explore the prognostic risk factors of ESD curative resection of gastrointestinal-neuroendocrine neoplasms (GI-NENs).
A total of 97 patients treated with ESD successfully in our hospital were selected, their surgical site, size, number of resection lesions, operation time, intraoperative complications (such as bleeding and perforation), and treatment status were recorded, and the number of hemostatic clamps used after the postoperative follow-up results and the independent risk factors for ESD complications were obtained through the comparison between the noncomplication group and the ESD complication group using regression analysis.
A total of 97 patients with gastrointestinal neuroendocrine tumors were treated with ESD. 61 were males, 36 were females, the ratio of male to female was 1.7 : 1, onset age was 20-78 years old, and median onset age was 50 years old. In 81 cases, tumors were located in the stomach, 10 in the duodenum, and 6 in the rectum. A total of 103 lesions were detected by endoscopy, including 1 case with 2 sites in the stomach, 5 cases with 2 sites in the rectum, and the rest were single. The tumor diameter was 0.3 ∼ 2.5 cm, and the median diameter was 0.6 cm; there were 25 sites with a diameter less than 5 cm. There were 57 places with 10 mm, 16 places with 10-15 mm, and 5 places with >15 mm. All ESD operations were performed in one piece, with a total resection rate of 100%; 89.6% (60/67) of postoperative pathology showed negative basal, and 90.3% (56/62) showed negative resection margin, with a complete resection rate of 88.9% (48/54). ESD's operation time is 6 ∼ 66 min, and the median time is 18 min. During the operation, 5 cases had small amount of bleeding, 3 cases were perforated, 2 cases of delayed postoperative bleeding, 1 case of bleeding was caused by the patient's failure to follow the advice of the doctor to eat a large amount of solid food too early, and 1 case of delayed perforation (all recovered and discharged). ESD operation that bled, age, gender, and perforation location, pathological grade, pathological classification, tumor diameter, tumor surface, operation time, number of titanium clips, origin, echo uniformity, and echo level were statistically insignificant ( > 0.05). Postoperative bleeding was related to the operation time (=0.017), but it was not an independent risk factor for postoperative bleeding (=0.118; OR, 0.226; 95% CI, 0.035-1.461). 59 cases were followed up by endoscopy after the operation, and recurrence or no new tumors were found.
ESD is an effective and safe treatment method for gastrointestinal neuroendocrine tumors with a diameter of 1-2 cm without invading the muscularis propria. The intraoperative complications seem to have little relationship with the patient; postoperative delayed bleeding is closely related to the ESD operation time but it is not an independent risk factor.
探讨内镜黏膜下剥离术(ESD)治疗胃肠神经内分泌肿瘤(GI-NENs)的预后危险因素。
选取我院成功行 ESD 治疗的 97 例患者,记录其手术部位、大小、切除病灶数、手术时间、术中并发症(如出血、穿孔)及治疗情况,通过术后随访结果比较非并发症组与 ESD 并发症组,获得术后使用止血夹的数量及 ESD 并发症的独立危险因素,并采用回归分析进行比较。
97 例胃肠神经内分泌肿瘤患者行 ESD 治疗,男 61 例,女 36 例,男女比例为 1.7:1,发病年龄 20-78 岁,中位发病年龄 50 岁。81 例肿瘤位于胃,10 例位于十二指肠,6 例位于直肠。内镜共检出 103 个病灶,其中胃 2 个部位 1 例,直肠 2 个部位 5 例,其余均为单个病灶。肿瘤直径 0.3-2.5cm,中位直径 0.6cm;直径<5cm 者 25 例。直径 10mm 者 57 个部位,10-15mm 者 16 个部位,>15mm 者 5 个部位。所有 ESD 手术均一次性整块切除,整块切除率 100%;术后病理基底均阴性 60/67(89.6%),切缘均阴性 56/62(90.3%),完全切除率 88.9%(48/54)。ESD 手术时间 6-66min,中位时间 18min。术中 5 例少量出血,3 例穿孔,2 例术后延迟出血,1 例因患者未遵医嘱过早大量进食固体食物而出血,1 例延迟穿孔(均痊愈出院)。ESD 术中出血与年龄、性别、穿孔部位、病理分级、病理分类、肿瘤直径、肿瘤表面、手术时间、钛夹数量、起源、回声均匀性、回声水平无关(>0.05)。术后出血与手术时间相关(=0.017),但不是术后出血的独立危险因素(=0.118;OR,0.226;95%CI,0.035-1.461)。术后 59 例行内镜随访,未见复发或新病灶。
ESD 是治疗直径 1-2cm 未侵犯固有肌层的胃肠神经内分泌肿瘤的有效且安全的方法,术中并发症似乎与患者关系不大;术后迟发性出血与 ESD 手术时间密切相关,但不是独立的危险因素。